SG Americas Securities
GH icon

SG Americas Securities’s Guardant Health GH Stock Holding History

SG Americas Securities’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80,000
Closed -$224K – 3169
2022
Q3 		$224K Buy
+80,000
New +$4.11M ﹤0.01% 2224

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SG Americas Securities's GH Position: Q2 2026 in Review

SG Americas Securities increased its Guardant Health (GH) stake by 63% in Q2 2026, buying an estimated $1.53M and bringing the position to 36,270 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

SG Americas Securities first reported a position in GH in Q1 2019 and has held it in 25 quarters since. The position peaked at $8.85M in Q3 2021. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • SG Americas Securities held 36,270 shares of Guardant Health worth $5.44M as of Q2 2026.
  • SG Americas Securities bought 14,026 Guardant Health shares in Q2 2026, an estimated $1.53M.
  • Guardant Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1055 holding.
  • SG Americas Securities first reported a position in Guardant Health in Q1 2019 and has held it in 25 quarters since.
  • SG Americas Securities's Guardant Health position peaked at $8.85M in Q3 2021.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.